More articles from 1-Minute Consult

  • Is chest radiography routinely needed after thoracentesis?
    Aibek E. Mirrakhimov, MD, Aram Barbaryan, MD, Taha Ayach, MD, Fabrizio Canepa Escaro, MD, Goutham Talari, MD and Adam Gray, MD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 371-373; DOI: https://doi.org/10.3949/ccjm.86a.17058

    No, it should be done only in certain situations, for example, if pneumothorax is suspected.

  • Can procalcitonin guide decisions about antibiotic management?
    Robert J. Fakheri, MD
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 307-311; DOI: https://doi.org/10.3949/ccjm.86a.18074

    Yes, but clinical judgment must still be exercised.

  • How should I treat acute agitation in pregnancy?
    Joshua D. Niforatos, MTS, Jonathon W. Wanta, MD, Anna P. Shapiro, MD, Justin A. Yax, Do, DTMH and Adele C. Viguera, MD, MPH
    Cleveland Clinic Journal of Medicine April 2019, 86 (4) 243-247; DOI: https://doi.org/10.3949/ccjm.86a.18041

    This is an obstetric emergency. Intervention should progress in a stepwise manner.

  • Does early repolarization on ECG increase the risk of cardiac death in healthy people?
    Ziad Sayedahmad, MD, Fahed Darmoch, MD, Yasser Al-Khadra, MD, Amjad Kabach, MD and M. Chadi Alraies, MD
    Cleveland Clinic Journal of Medicine March 2019, 86 (3) 165-166; DOI: https://doi.org/10.3949/ccjm.86a.17032

    No. In patients without symptoms, early repolarization is nearly always a benign incidental finding.

  • Repeating blood cultures after initial bacteremia: When and how often?
    Ammara Mushtaq, MD, Bryce X. Bredell, MS and Ayman O. Soubani, MD
    Cleveland Clinic Journal of Medicine February 2019, 86 (2) 89-92; DOI: https://doi.org/10.3949/ccjm.86a.18001

    Repeating blood cultures after an initial positive result is superfluous except in certain situations.

  • Should metformin be used in every patient with type 2 diabetes?
    Vinni Makin, MBBS, MD, FACE and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 17-20; DOI: https://doi.org/10.3949/ccjm.86a.18039

    Most patients should receive it, with exceptions. Nevertheless, it is underused.

  • When can I stop dual antiplatelet therapy in patients with drug-eluting stents?
    Juan Simon Rico-Mesa, MD, Carlos Uribe, MD, FACC, FSCAI, Megha Prasad, MD and Sushil Allen Luis, MBBS, FRACP
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 13-16; DOI: https://doi.org/10.3949/ccjm.86a.17033

    The decision requires balancing the risk of thrombosis against the risk of bleeding. A cardiologist can help.

  • Do all hospital inpatients need cardiac telemetry?
    Motaz Baibars, MD, Yasser Al-Khadra, MD, Zaher Fanari, MD, Homam Moussa Pacha, MD, Mohamad Soud, MD and M. Chadi Alraies, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 925-927; DOI: https://doi.org/10.3949/ccjm.85a.17114

    Routine cardiac telemetry raises costs and does little.

  • What can I do when first-line measures are not enough for vasovagal syncope?
    Erika Hutt-Centeno, MD and Kenneth A. Mayuga, MD, FHRS, FACC, FACP
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 920-922; DOI: https://doi.org/10.3949/ccjm.85a.17112

    Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.

  • Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
    Gregory T. Brennan, MD, Alex Duong, Emily T. Nguyen, PharmD and Douglas L. Nguyen, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 923-924; DOI: https://doi.org/10.3949/ccjm.85a.18037

    Active IBD poses a greater risk than continuing drug therapy.

Pages